SS Innovations International, Inc. (NASDAQ: SSII) provided an update on the continued expansion and utilization of its SSi Mantra surgical robotic system, reporting 14,103 cumulative procedures as of Sept. 8, 2026, up 79% from 7,885 at year-end 2025. The installed base increased 42% to 238 systems from 168, according to the company's report.
The SSi Mantra is now installed across 12 countries, with approximately 1,500 physicians trained on the platform. The system has been used for more than 170 types of surgical procedures. Recent international milestones include the launch of robotic cardiac surgery in Colombia, installation of the first SSi Mantra in Sri Lanka, and the first telesurgery within the Philippines.
SS Innovations also highlighted 258 cumulative pediatric robotic surgeries and 188 robotic telesurgeries as of Aug. 31, including a more than 13,600-mile telesurgery between Colombia and India. In August, five SSi Mantra systems were used to complete 50 robotic general surgery procedures in a single day in India.
Looking ahead, the company expects the U.S. Food and Drug Administration to complete its review of the SSi Mantra 510(k) premarket notification by the end of the first quarter of 2027 and believes European Union CE marking certification can be obtained by year-end 2026. These regulatory milestones are critical for expanding into major markets and could significantly boost the company's addressable market.
The growth in procedures and installations underscores the increasing adoption of robotic surgery, particularly in emerging markets where access to advanced surgical care has been limited. SS Innovations aims to make robotic surgery affordable and accessible to a larger segment of the global population through its SSi Mantra system and SSi Mudra surgical instruments, which support a variety of procedures including cardiac surgery.
For business leaders and investors in the medical technology sector, SS Innovations' performance signals a growing demand for cost-effective robotic surgical solutions. The company's expansion into new countries and the upcoming regulatory decisions could position it as a formidable competitor in the global surgical robotics market, which has traditionally been dominated by larger players. The ability to perform telesurgery across vast distances also opens up possibilities for remote surgical care, potentially transforming healthcare delivery in underserved regions.
To view the full report, visit https://ibn.fm/DJILj. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII.
